Theorem Clinical Research

AstraZeneca

MD Anderson, MedImmune collaborate on cancer immunotherapy

Monday, March 17, 2014 01:42 PM

The University of TexasMD Anderson Cancer Center and MedImmune, the global biologics R&D arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers.

More... »


AstraZeneca sells Alderley Park site in Cheshire, U.K.

Wednesday, March 12, 2014 01:41 PM

AstraZeneca has sold its Alderley Park site in Cheshire, U.K., to Manchester Science Parks(MSP), a Greater Manchester-based public-private partnership and science park operator.

More... »


AstraZeneca, Korea Health Industry Development Institute partner

Monday, March 10, 2014 11:53 AM

AstraZeneca has signed a memorandum of understanding (MOU) with the Korea Health Industry Development Institute (KHIDI), a government-funded institution aiming to enhance global competitiveness of the healthcare industry, to establish an Oncology Research Program.

More... »

AstraZeneca scientists to work alongside researchers at Cancer Research UK Cambridge

Monday, February 24, 2014 11:38 AM

AstraZeneca has entered into a collaboration with the Cancer Research U.K. (CRUK) Cambridge Institute to temporarily locate up to 60 AstraZeneca scientists in the Institute.

More... »

Medimmune, UC San Francisco collaborate

Friday, February 14, 2014 01:40 PM

MedImmune, the global biologics R&D arm of AstraZeneca, has entered a three-year collaboration with the Clinical and Translational Science Institute (CTSI) at the University of California, San Francisco (UCSF).  The collaboration will focus on CTSI's Catalyst Awards program, which solicits applications from University scientists who wish to move their translational research beyond the bench and into product development.

More... »

ACRES, HealthCarePoint strengthen partnership

Wednesday, February 5, 2014 01:18 PM

HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking-technology company, and the Alliance for Clinical Research Excellence and Safety (ACRES), a Cambridge-based nonprofit organization dedicated to enhancing quality, safety, integrity and operational effectiveness in drug development and health research, have announced a second step in their previously announced strategic alliance.

More... »

Bristol-Myers Squibb completes sale of global diabetes business to AstraZeneca

Monday, February 3, 2014 08:51 AM

Bristol-Myers Squibb has completed the previously announced sale of its global diabetes business to AstraZeneca.

More... »

Astrazeneca to close India R&D site

Friday, January 31, 2014 12:49 PM

AstraZeneca plans to close its Avishkar R&D site in Bangalore later this year, part of the company's broader global business strategy to simplify its R&D footprint and focus resources on three core therapy areas: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity.

More... »

FOB Synthesis, AstraZeneca collaborate on antibiotic-resistant bacterial infections

Wednesday, January 29, 2014 01:02 PM

FOB Synthesis, a chemistry-driven drug discovery and custom synthesis company, has entered into an R&D option and license agreement with AstraZeneca for the development of a novel antibiotic to treat drug-resistant bacterial infections. The treatment will potentially combine compounds from AstraZeneca's preclinical beta lactamase inhibitor (BLI) and FOB Synthesis' preclinical Carbapenem antibiotic programs to help break down bacteria's resistance to carbapenems.

More... »

PTC Therapeutics expands management team

Monday, January 27, 2014 02:47 PM

PTC Therapeutics has expanded its senior management team with the appointment of Robert J. Spiegel, M.D., FACP, to chief medical officer and Murad Husain to vice president, Global Regulatory Affairs. PTC also announced the promotions of Joseph Colacino, Ph.D., to senior vice president, Drug Discovery and Ernest R. Dietel to senior vice president, Quality. In addition, Jay Barth, M.D., senior vice president of Clinical Development, is leaving PTC to pursue other opportunities.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 29

WCG sees ePharmaSolutions’ clinical trial portal as the next step in the data evolution, company mission

Cutting-edge advertising can ‘break through the clutter’ for successful patient recruitment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs